Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies

Journal of Diabetes Investigation

Volumn 3, Issue 1, 2012, Pages 62-69

  Tsutsumi, Chiharu ^a   Imagawa, Akihisa ^a   Ikegami, Hiroshi ^b   Makino, Hideichi ^c   Kobayashi, Tetsuro ^d   Hanafusa, Toshiaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Shiraishi Hospital Diabetes Center   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Fulminant type 1 diabetes; Glutamic acid decarboxylase; HLA

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FULMINANT TYPE 1 DIABETES; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA DQB1 GENE; HLA DRB1 GENE; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84863128011     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2011.00139.x     Document Type: Article

References (32)

1. Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 2000; 342: 301-307.
2. Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003; 26: 2345-2352.
3. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 2007; 3: 36-45.
4. Cho YM, Kim JT, Ko KS, et al. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 2007; 50: 2276-2279.
5. Kim NH, Kim HY, Seo JA, et al. A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan. Diabetes Res Clin Pract 2009; 86: e43-e45.
6. Zheng C, Zhou Z, Yang L, et al. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes Metab Res Rev 2011; 27: 70-78.
7. Chiou CC, Chung WH, Hung SI, et al. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpes virus 6 infection. J Am Acad Dermatol 2006; 2(Suppl): S14-S17.
8. Taniyama M, Katsumata R, Aoki K, et al. A Filipino patient with fulminant type 1 diabetes. Diabetes Care 2004; 27: 842-843.
9. Tan F, Loh WK. Fulminant type 1 diabetes associated with pregnancy: a report of 2 cases from Malaysia. Diabetes Res Clin Pract 2010; 90: e30-e32.
10. Moreau C, Drui D, Arnault-Ouary G, et al. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 2008; 34: 529-532.
11. Kawasaki E, Imagawa A, Makino H, et al. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 2008; 31: 1608-1610.
12. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 2005; 48: 294-300.
13. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 2009; 52: 2513-2521.
14. Shimada A, Maruyama T. Encephalomyocarditis-virus-induced diabetes model resembles "fulminant" type 1 diabetes in humans. Diabetologia 2004; 47: 1854-1855
15. Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia 2005; 48: 290-293.
16. Sano H, Terasaki J, Tsutsumi C, et al. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract 2008; 79: e8-e9.
17. Akatsuka H, Yano Y, Gabazza EC, et al. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract 2009; 84: e50-e52.
18. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009; 58: 2285-2291.
19. Shibasaki S, Imagawa A, Tauriainen S, et al. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J 2010; 57: 211-219.
20. Tanaka S, Kobayashi T, Nakanishi K, et al. Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type1 diabetes. Diabetes Care 2002; 25: 2302-2307.
21. Nakamura T, Nagasaka S, Kusaka I, et al. HLA-DR-DQ haplotype in rapid-onset type 1 diabetes in Japanese. Diabetes Care 2003; 26: 1640-1641.
22. Katahira M, Ishiguro T, Segawa S, et al. Reevaluation of human leukocyte antigen DR-DQ haplotype and genotype in type 1 diabetes in the Japanese population. Horm Res 2008; 69: 284-289.
23. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 2002; 25: 995-1001.
24. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010; 1: 212-228.
25. Kasuga A, Shimada A, Ozawa Y, et al. IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese. Endocr J 2000; 47: 57-62.
26. Saito S, Ota S, Yamada E, et al. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000; 56: 522-529.
27. Ikegami H, Kawaguchi Y, Yamato E, et al. Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992; 75: 1381-1385.
28. Awata T, Kuzuya T, Matsuda A, et al. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1992; 35: 419-424.
29. Ikegami H, Ogihara T. Genetics of insulin-dependent diabetes mellitus. Endocr J 1996; 43: 605-613.
30. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002; 51: 545-551.
31. Murao S, Makino H, Kaino Y, et al. Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 2004; 53: 2684-2690.
32. Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type1 diabetes associated with pregnancy. J Clin Endocrinol Metab 2006; 91: 471-476.